Market Cap 3.06B
Revenue (ttm) 125.60M
Net Income (ttm) -2.03B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,613.86%
Debt to Equity Ratio 0.00
Volume 838,621
Avg Vol 1,070,808
Day's Range N/A - N/A
Shares Out 36.05M
Stochastic %K 48%
Beta 4.31
Analysts Sell
Price Target $61.50

Company Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing,...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 833 694 2553
Website: grail.com
Address:
1525 O’Brien Drive, Menlo Park, United States
Bazzzigar
Bazzzigar Nov. 14 at 8:21 PM
$GRAL HIMS
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:59 PM
Hedge Alert Live - Protect Your Portfolio Contract: $GRAL $80.00 Put · NOV 21, 2025 Exp Entry Price: $4.40 - $4.70 Exit Price Target: $7.90 Profit Margin: +68% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
smartkarma
smartkarma Nov. 14 at 6:55 PM
$GRAL | GRAIL Inc. (GRAL.US): 3Q’FY25 Revenue In Line; Galleri PMA Submission To FDA Approaches "​GRAIL Inc. anticipates FDA submission for Galleri in 1Q’FY26, with strong cash position and leadership in MCED testing market in the United States." - Andrei Zakharov Read more: https://www.smartkarma.com/insights/grail-inc-gral-us-3q-fy25-revenue-in-line-galleri-pma-submission-to-fda-approaches
0 · Reply
BringDownThoseReps
BringDownThoseReps Nov. 14 at 2:58 PM
$GRAL laughing
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 14 at 2:01 PM
$GRAL (-5.5% pre) GRAIL establishes $300 million at-the-market stock offering program https://ooc.bz/l/84609
0 · Reply
healthcareguru
healthcareguru Nov. 14 at 12:29 PM
$GRAL WHAT DID I SAY?!?!? 😂😂👎👎 $50 incoming…
0 · Reply
BringDownThoseReps
BringDownThoseReps Nov. 14 at 11:22 AM
$GRAL homeboy practically all of your "time to short this POS" posts were immediately followed by face ripping rallies. You can't pull that on us - the record is there for all to see 🤣🤣🤣 Don't worry though the food banks may be restocked for thanksgiving!
1 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 8:18 AM
Hedge Alert Live - Protect Your Portfolio Contract: $GRAL $80.00 Put · NOV 21, 2025 Exp Entry Price: $4.34 - $5.40 Exit Price Target: $7.86 Profit Margin: +81% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 5:08 AM
$GRAL: The last close at $83.2 indicates a position above the 30-day moving average (MA30) of $79.93, suggesting bullish potential. However, the RSI at 43.03 indicates a neutral to slightly bearish momentum, as it is below the 50 threshold. The price is significantly below the 60-day high of $103.0, which could act as resistance, while the 60-day low of $30.82 provides a solid support level. Directional bias: Neutral to bullish, given the proximity to MA30 and the recent price action. Suggested entry: Consider entering at $84.5, slightly above the last close to confirm upward momentum. Stop loss: Set at $78.5, below the MA30 for protection against downside risk. Targets: First target at $92.0, near the 60D high, and a second target at $98.0, a psychological resistance level. This plan leverages the existing metrics while managing risk effectively. https://privateprofiteers.com
0 · Reply
healthcareguru
healthcareguru Nov. 14 at 2:28 AM
$GRAL as soon as they stopped spewing BS at that terrible meeting today, they turned and stabbed you in the back immediately: more dilution brewing… CASH INCINERATION = problematic. 🐺👎 $XLV $XBI $IWM https://www.sec.gov/Archives/edgar/data/1699031/000162828025052027/grail-sx3.htm
0 · Reply
Latest News on GRAL
GRAIL, Inc. (GRAL) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 6:21 PM EST - 1 day ago

GRAIL, Inc. (GRAL) Q3 2025 Earnings Call Transcript


GRAIL Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 4:02 PM EST - 1 day ago

GRAIL Reports Third Quarter 2025 Financial Results


Top Biotech Stocks Riding The Rally

Nov 4, 2025, 3:15 PM EST - 10 days ago

Top Biotech Stocks Riding The Rally

CTMX GRFS INCY


GRAIL to Announce Third Quarter 2025 Financial Results

Oct 29, 2025, 4:02 PM EDT - 16 days ago

GRAIL to Announce Third Quarter 2025 Financial Results


GRAIL: Buy Τhe Test That Could Redefine Cancer Screening

Oct 27, 2025, 7:00 AM EDT - 18 days ago

GRAIL: Buy Τhe Test That Could Redefine Cancer Screening


What's Happening With GRAIL Stock?

Oct 17, 2025, 9:55 AM EDT - 4 weeks ago

What's Happening With GRAIL Stock?


Grail: A Speculative Buy

Sep 30, 2025, 12:17 PM EDT - 6 weeks ago

Grail: A Speculative Buy


mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 2 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR ILMN IONS MRNA RGEN


GRAIL, Inc. (GRAL) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 7:13 PM EDT - 3 months ago

GRAIL, Inc. (GRAL) Q2 2025 Earnings Call Transcript


GRAIL Reports Second Quarter 2025 Financial Results

Aug 12, 2025, 4:02 PM EDT - 3 months ago

GRAIL Reports Second Quarter 2025 Financial Results


GRAIL to Announce Second Quarter 2025 Financial Results

Jul 29, 2025, 4:02 PM EDT - 3 months ago

GRAIL to Announce Second Quarter 2025 Financial Results


The Holy Grail of Automation: Now a Robot Can Unload a Truck

Jun 23, 2025, 5:30 AM EDT - 5 months ago

The Holy Grail of Automation: Now a Robot Can Unload a Truck


Grail Shares Jump on Promising Results for Galleri Study

Jun 18, 2025, 12:43 PM EDT - 5 months ago

Grail Shares Jump on Promising Results for Galleri Study


GRAIL to Present at Jefferies Global Healthcare Conference 2025

May 21, 2025, 4:05 PM EDT - 6 months ago

GRAIL to Present at Jefferies Global Healthcare Conference 2025


GRAIL, Inc. (GRAL) Q1 2025 Earnings Call Transcript

May 13, 2025, 7:16 PM EDT - 6 months ago

GRAIL, Inc. (GRAL) Q1 2025 Earnings Call Transcript


GRAIL Reports First Quarter 2025 Financial Results

May 13, 2025, 4:01 PM EDT - 6 months ago

GRAIL Reports First Quarter 2025 Financial Results


GRAIL to Announce First Quarter 2025 Financial Results

Apr 29, 2025, 4:01 PM EDT - 7 months ago

GRAIL to Announce First Quarter 2025 Financial Results


GRAIL's Galleri Progresses While Back In Accumulation Levels

Apr 12, 2025, 9:32 AM EDT - 7 months ago

GRAIL's Galleri Progresses While Back In Accumulation Levels


How Does GRAIL Benefit From The Proposed MCED Legislation?

Apr 8, 2025, 9:49 AM EDT - 7 months ago

How Does GRAIL Benefit From The Proposed MCED Legislation?


GRAIL to Present at TD Cowen 45th Annual Health Care Conference

Feb 21, 2025, 9:00 AM EST - 9 months ago

GRAIL to Present at TD Cowen 45th Annual Health Care Conference


GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 10:09 PM EST - 9 months ago

GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript


GRAIL to Announce Fourth Quarter 2024 Financial Results

Feb 12, 2025, 4:02 PM EST - 9 months ago

GRAIL to Announce Fourth Quarter 2024 Financial Results


Bazzzigar
Bazzzigar Nov. 14 at 8:21 PM
$GRAL HIMS
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:59 PM
Hedge Alert Live - Protect Your Portfolio Contract: $GRAL $80.00 Put · NOV 21, 2025 Exp Entry Price: $4.40 - $4.70 Exit Price Target: $7.90 Profit Margin: +68% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
smartkarma
smartkarma Nov. 14 at 6:55 PM
$GRAL | GRAIL Inc. (GRAL.US): 3Q’FY25 Revenue In Line; Galleri PMA Submission To FDA Approaches "​GRAIL Inc. anticipates FDA submission for Galleri in 1Q’FY26, with strong cash position and leadership in MCED testing market in the United States." - Andrei Zakharov Read more: https://www.smartkarma.com/insights/grail-inc-gral-us-3q-fy25-revenue-in-line-galleri-pma-submission-to-fda-approaches
0 · Reply
BringDownThoseReps
BringDownThoseReps Nov. 14 at 2:58 PM
$GRAL laughing
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 14 at 2:01 PM
$GRAL (-5.5% pre) GRAIL establishes $300 million at-the-market stock offering program https://ooc.bz/l/84609
0 · Reply
healthcareguru
healthcareguru Nov. 14 at 12:29 PM
$GRAL WHAT DID I SAY?!?!? 😂😂👎👎 $50 incoming…
0 · Reply
BringDownThoseReps
BringDownThoseReps Nov. 14 at 11:22 AM
$GRAL homeboy practically all of your "time to short this POS" posts were immediately followed by face ripping rallies. You can't pull that on us - the record is there for all to see 🤣🤣🤣 Don't worry though the food banks may be restocked for thanksgiving!
1 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 8:18 AM
Hedge Alert Live - Protect Your Portfolio Contract: $GRAL $80.00 Put · NOV 21, 2025 Exp Entry Price: $4.34 - $5.40 Exit Price Target: $7.86 Profit Margin: +81% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 5:08 AM
$GRAL: The last close at $83.2 indicates a position above the 30-day moving average (MA30) of $79.93, suggesting bullish potential. However, the RSI at 43.03 indicates a neutral to slightly bearish momentum, as it is below the 50 threshold. The price is significantly below the 60-day high of $103.0, which could act as resistance, while the 60-day low of $30.82 provides a solid support level. Directional bias: Neutral to bullish, given the proximity to MA30 and the recent price action. Suggested entry: Consider entering at $84.5, slightly above the last close to confirm upward momentum. Stop loss: Set at $78.5, below the MA30 for protection against downside risk. Targets: First target at $92.0, near the 60D high, and a second target at $98.0, a psychological resistance level. This plan leverages the existing metrics while managing risk effectively. https://privateprofiteers.com
0 · Reply
healthcareguru
healthcareguru Nov. 14 at 2:28 AM
$GRAL as soon as they stopped spewing BS at that terrible meeting today, they turned and stabbed you in the back immediately: more dilution brewing… CASH INCINERATION = problematic. 🐺👎 $XLV $XBI $IWM https://www.sec.gov/Archives/edgar/data/1699031/000162828025052027/grail-sx3.htm
0 · Reply
angelinvesting369
angelinvesting369 Nov. 14 at 1:45 AM
$PLTR $GRAL 2 most important companies in the entire market
0 · Reply
healthcareguru
healthcareguru Nov. 14 at 1:13 AM
$GRAL weird… 😂👎😘
0 · Reply
BringDownThoseReps
BringDownThoseReps Nov. 14 at 12:02 AM
$GRAL here's what you "told us" lmao 🤣🤣🤣
1 · Reply
d_risk
d_risk Nov. 13 at 9:50 PM
$GRAL - GRAIL Inc. Common Stock - 10Q - Updated Risk Factors GRAL’s risk factors now highlight operational performance, regulatory hurdles (notably FDA PMA for Galleri), NHS trial delays, evolving FDA oversight, expanded international and geopolitical risks, and new warnings on government disruptions affecting test development and approval. #Biotechnology #OperationalPerformance #GeopoliticalRisk #FDAApproval #RegulatoryRisk 🟢 Added 🟠 Removed https://d-risk.ai/GRAL/10-Q/2025-11-13
0 · Reply
healthcareguru
healthcareguru Nov. 13 at 7:32 PM
$GRAL I told you…nothing new except actually pretty negative comments on pricing trends…this is hard sell the news after a crap qtr and trading at an insane 18x fwd EV/sales. 👎
0 · Reply
BringDownThoseReps
BringDownThoseReps Nov. 13 at 7:29 PM
$GRAL coyote
1 · Reply
healthcareguru
healthcareguru Nov. 13 at 4:10 PM
$GRAL that CFO update was pathetic…not to mention they aren’t really growing sequentially. Really bad sign for arc of growth trajectory. This should be down 20%+ today… 🐺👎
1 · Reply
healthcareguru
healthcareguru Nov. 13 at 4:02 PM
$GRAL this is straight sell the news 👎
0 · Reply
angelinvesting369
angelinvesting369 Nov. 13 at 3:46 PM
$GRAL 🌍
0 · Reply
healthcareguru
healthcareguru Nov. 13 at 3:17 PM
$GRAL short this crap all day…that quarter was garbage. Missed on screening revenues and bigger EBITDA loss…this has at least 50% downside on tap to reality. 👎🐺
0 · Reply
CapitalGains007
CapitalGains007 Nov. 13 at 2:59 PM
$GRAL we will see
3 · Reply
CapitalGains007
CapitalGains007 Nov. 13 at 2:58 PM
$GRAL Samsung they like $100M at this like it’s a penny stock. Means nothing.
3 · Reply